Unknown

Dataset Information

Comparing Australian orthopaedic surgeons' reported use of thromboprophylaxis following arthroplasty in 2012 and 2017.


ABSTRACT:

Background

It is generally accepted that all arthroplasty patients should receive venous thromboembolism (VTE) and bleeding risk assessments, and that postoperative thromboprophylaxis be routinely prescribed where appropriate. Guideline recommendations regarding what to prescribe, however, have been inconsistent over the years, particularly regarding the appropriateness of aspirin. Our aim was to explore thromboprophylaxis patterns in use following hip and knee arthroplasty in Australia, and to examine associated variables.

Methods

Orthopaedic surgeons were invited via mail to participate in two national surveys, conducted in 2012 (N = 478) and 2017 (N = 820), respectively.

Results

The final response rates were 50.0 and 65.8% for 2012 and 2017, respectively. The throm

SUBMITTER: Mirkazemi C 

PROVIDER: S-EPMC6368726 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature